ASGN (NYSE:ASGN - Get Free Report) issued an update on its fourth quarter 2025 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 1.120-1.200 for the period, compared to the consensus estimate of 1.160. The company issued revenue guidance of $960.0 million-$980.0 million, compared to the consensus revenue estimate of $970.2 million.
ASGN Stock Performance
NYSE:ASGN traded up $0.30 during trading on Wednesday, reaching $48.32. The company's stock had a trading volume of 915,274 shares, compared to its average volume of 542,209. The firm has a market cap of $2.12 billion, a price-to-earnings ratio of 15.29 and a beta of 0.93. The company has a debt-to-equity ratio of 0.66, a quick ratio of 2.11 and a current ratio of 2.11. The firm has a 50 day moving average of $50.22 and a 200-day moving average of $52.07. ASGN has a 12 month low of $45.10 and a 12 month high of $101.66.
ASGN (NYSE:ASGN - Get Free Report) last announced its quarterly earnings data on Wednesday, October 22nd. The business services provider reported $1.31 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.22 by $0.09. ASGN had a return on equity of 11.90% and a net margin of 3.50%. ASGN has set its Q4 2025 guidance at 1.120-1.200 EPS. Research analysts expect that ASGN will post 5.15 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
A number of research analysts have issued reports on ASGN shares. Weiss Ratings restated a "sell (d+)" rating on shares of ASGN in a research note on Wednesday, October 8th. Truist Financial dropped their price target on ASGN from $75.00 to $65.00 and set a "buy" rating on the stock in a research report on Monday, October 13th. Zacks Research raised ASGN from a "strong sell" rating to a "hold" rating in a research report on Tuesday, August 19th. Wells Fargo & Company dropped their price target on ASGN from $56.00 to $51.00 and set an "equal weight" rating on the stock in a research report on Thursday, July 24th. Finally, Jefferies Financial Group reaffirmed an "underperform" rating and set a $42.00 price target (down previously from $53.00) on shares of ASGN in a research report on Monday, July 7th. Two equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat.com, ASGN currently has an average rating of "Reduce" and an average target price of $60.00.
Read Our Latest Stock Report on ASGN
About ASGN
(
Get Free Report)
ASGN Incorporated engages in the provision of information technology (IT) services and solutions in the technology, digital, and creative fields for commercial and government sectors in the United States, Canada, and Europe. It operates through two segments: Commercial and Federal Government. The Commercial Segment provides consulting, creative digital marketing, and permanent placement services primarily to enterprise clients.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider ASGN, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ASGN wasn't on the list.
While ASGN currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.